Porino VA

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted pyridines as PARP1 inhibitors
- Patent number 12,006,322
- Issue date Jun 11, 2024
- Xin Thera, Inc.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PARP1 inhibitors and uses thereof
- Patent number 11,939,329
- Issue date Mar 26, 2024
- XinThera, Inc.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azetidine and pyrrolidine PARP1 inhibitors and uses thereof
- Patent number 11,802,128
- Issue date Oct 31, 2023
- XINTHERA, INC.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridines as PARP1 inhibitors
- Patent number 11,795,173
- Issue date Oct 24, 2023
- XINTHERA, INC.
- Robert L Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions as toll-like receptor 7 agonists
- Patent number 9,902,730
- Issue date Feb 27, 2018
- Novartis AG
- Yongkai Li
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS
- Publication number 20240400569
- Publication date Dec 5, 2024
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20240368162
- Publication date Nov 7, 2024
- Xinthera, Inc.
- Qing DONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF
- Publication number 20240279214
- Publication date Aug 22, 2024
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS
- Publication number 20240109904
- Publication date Apr 4, 2024
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS
- Publication number 20230348473
- Publication date Nov 2, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230234952
- Publication date Jul 27, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230203033
- Publication date Jun 29, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230159525
- Publication date May 25, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230128041
- Publication date Apr 27, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20220348574
- Publication date Nov 3, 2022
- Xinthera, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS
- Publication number 20170057968
- Publication date Mar 2, 2017
- Novartis AG
- Yongkai LI
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Substituted pyridines as PARP1 inhibitors

PARP1 inhibitors and uses thereof

Azetidine and pyrrolidine PARP1 inhibitors and uses thereof

Substituted pyridines as PARP1 inhibitors

Compounds and compositions as toll-like receptor 7 agonists

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS

PARP1 INHIBITORS AND USES THEREOF

ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF

SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS

SUBSTITUTED PYRIDINES AS PARP1 INHIBITORS

PARP1 INHIBITORS AND USES THEREOF

AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF

AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS